Objective: Cigarette smoking has been recognized as an important risk factor for pancreas cancer, but the magnitude of the association may vary among geographical areas. Therefore, we reviewed epidemiologic studies on the association between cigarette smoking and pancreas cancer in the Japanese population. Methods: Original data were obtained from MEDLINE searched using PubMed or from searches of the Ichushi database, complemented with manual searches. Evaluation of associations was based on the strength of evidence ('convincing', 'probable', 'possible' or 'insufficient') and the magnitude of association ('strong', 'moderate', 'weak' or 'no association'), together with biological plausibility as previously evaluated by the International Agency of Research on Cancer. Results: We identified four cohort studies and three case -control studies. All cohort studies consistently showed positive associations between pancreas cancer and cigarette smoking, although statistical significance in each study is variable. Most of the cohort studies consistently showed that cigarette smoking had a dose-response relationship with pancreas cancer. One case -control study showed a strong positive association, but the rest did not show any association. Meta-analysis of seven studies indicated that a summary estimate for ever smoking relative to never smoking was 1.68 (95% confidence interval: 1.38-2.05). Conclusions: We conclude that there is convincing evidence that cigarette smoking moderately increases the risk of pancreas cancer in the Japanese population.
BACKGROUND
An association between cigarette smoking and the risk of pancreas cancer has been consistently reported from all over the world. In the evaluation by the International Agency for Research on Cancer (IARC), tobacco smoke is classified as a Group 1 carcinogenic agent to humans causing cancer including pancreas cancer (1) . Thus, cigarette smoking is one of the internationally well-established risk factors of pancreas cancer.
On the other hand, the risk of pancreas cancer by cigarette smoking might vary among geographical areas because of a large variability in the patterns of tobacco consumption across countries. Genetic differences might also influence association between smoking and pancreas cancer risk. Therefore, the magnitude of the association between cigarette smoking and pancreas cancer in the Japanese population might differ from that in other regions.
We review epidemiological studies on cigarette smoking and pancreas cancer risk among Japanese. This report is one of a series of articles by our research group (2 -17) , which is investigating the association between lifestyle and the major types of cancer in Japan.
METHODS

SEARCH OF RESEARCH ON THE SUBJECT
The details of the evaluation method have been described elsewhere (2) . In brief, original data for this review were identified through searches of the MEDLINE (PubMed) and Ichushi (Japana Centra Revuo Medicina) databases, complemented by manual searches of references from relevant articles where necessary. All epidemiologic studies on the association between cigarette smoking and pancreas cancer incidence/mortality among the Japanese from 1950 (or 1983 for the Ichusi database) to June 2011, including papers in press if available, were identified using the following as keywords: cigarette, smoking, pancreas, pancreas cancer, cohort, follow-up, case -control, Japan and Japanese. Papers written in either English or Japanese were reviewed, and only studies on Japanese populations living in Japan were included. The individual results were summarized in tables separately as cohort or case -control studies. In the case of multiple publications of analyses of the same or overlapping data sets, only data from the largest or the most recent studies were included, and incidence was also given priority in a single publication describing both incidence and mortality.
EVALUATION OF STRENGTH OF ASSOCIATION BETWEEN CIGARETTE SMOKING AND PANCREAS CANCER RISK
An evaluation was made based on the magnitudes of association and the strength of evidence. First, the former was assessed by classifying the relative risk (RR) in each study into the following four categories, while considering statistical significance (SS) or no statistical significance (NS), as strong (symbol or ), ,0.5 or .2.0 (SS); moderate (symbol or ), either (i) ,0.5 or .2.0 (NS), (ii) .1.5 to 2 (SS) or (iii) 0.5 to ,0.67 (SS); weak (symbol or ), either (i) .1.5 to 2 (NS), (ii) 0.5 to ,0.67 (NS) or (iii) 0.67 to 1.5 (SS); or no association (symbol -), 0.67 to 1.5 (NS). When the multiple RRs were shown in the single study, we considered the largest RR. Criteria for the magnitude of association are summarized in Table 1 . After this process, the strength of evidence was evaluated in a similar manner to that used in the WHO/FAO Expert Consultation Report (18) , where evidence was classified as 'convincing', 'probable', 'possible' and 'insufficient'. In brief, the following criteria were used (2). Convincing: evidence based on a substantial number between exposure and disease, with little or no evidence to the contrary, with a biologically plausible association. Probable: evidence based on epidemiologic studies showing fairly consistent associations, but with perceived shortcomings in the available evidence or some evidence to the contrary that precludes a more definite judgment. Possible: evidence based mainly on findings from case -control and cross-sectional studies, requiring more studies to support the tentative associations, which should also be biologically plausible. Insufficient: evidence based on findings of a few studies that are suggestive, but insufficient to establish an association, requiring more welldesigned research to support the tentative associations. We assumed that biological plausibility corresponded to the judgment of the recent evaluation from the IARC (1). The final judgment is made based on the consensus of research group members.
QUANTITATIVE EVALUATION OF ASSOCIATION BY META-ANALYSIS
In addition, when there was 'convincing' or 'probable' evidence of a positive or inverse association, a meta-analysis was conducted to obtain summary estimates of the association. In general, studies that reported RRs and their confidence intervals (CIs) by comparing ever smokers with never or non-smokers were included in the meta-analysis. In case the subject study reported RRs separately according to multiple smoking status or levels, we estimated summary RRs for ever smokers relative to never or non-smokers by meta-analysis within the study, and the study-specific summary RR was included in the final meta-analysis. Studies without information on CIs and different reference categories were excluded from the meta-analysis. A general variance-based method was used to estimate summary statistics and their 95% CIs. Heterogeneity among studies was examined by testing the Q-statistic (19), with the model used to determine the summary RR and its 95% CI, namely a random-or fixed-effect model, selected according to the SS of the Q-statistic. A publication bias was assessed by using a funnel plot and an Egger's test (20) . Meta-analysis was done using the 'metan' and 'metabias' command of STATA statistical package version 11 (StataCorp LP, College Station, TX, USA).
MAIN FEATURES AND COMMENTS
After excluding one cohort study (21) due to the analysis of the overlapping data sets, we identified four cohort studies (22 -25) ( Table 2 ) and three case -control studies (26 -28) ( Table 3 ). All the cohort studies (26 -28) and one casecontrol study (28) presented the results by sex. The remaining two case -control studies presented the results for men and women combined (26, 27) . A summary of the magnitude of association for the cohort and case-control studies is shown in Tables 4 and 5 , respectively. All the cohort studies consistently showed positive association between cigarette smoking and pancreas cancer, although the significance of association varied across studies. Moreover, most of the cohort studies showed the dose -response or duration -response relationships between cigarette smoking and pancreas cancer risk in men (22, 24) and in women (25) . Among three case -control studies, one study showed strong association between cigarette smoking and pancreas cancer risk (26) . This study demonstrated a strong association between passive smoking in youth and pancreas cancer risk. Another case -control study showed a dose -response relationship in combined analysis of males and females or analysis of males only (28), although each point estimate for smoking did not reach SS.
In a comprehensive review by World Cancer Research Fund and American Cancer Research Institute, several risk/ protective factors were indicated with the levels of strength of evidence: body fatness as a convincing risk factor, folatecontaining foods as a probable protective factor, and abdominal fat and adult attained height as probable risk factors (29) . Status of consideration of these factors in the studies we reviewed need to be mentioned. Three out of four cohort studies that we reviewed considered anthropometric No studies considered folate consumption, and it is difficult to quantitatively judge the effect of this lack of consideration in our evaluation. This point should be addressed in a future pooled analysis which can consider folate consumption. In addition to the narrative review, we conducted a meta-analysis to clarify the magnitude of alcohol drinking among Japanese (Fig. 1) . A random-effect model was selected for the meta-analysis because heterogeneity tested by the Q-statistic was significant (Q ¼ 1.322, P ¼ 0.04). Egger's test to evaluate publication bias was not significant (P ¼ 0.229). Ever smokers had a significantly higher risk than never smokers (RR 1.68, 95% CI: 1.38 -2.05). This result was consistently observed when we limit studies to only cohort studies (RR 1.79, 13.9 -2.30). Smoking often confounds with sex and smoking was adjusted in all the studies. Sex-stratified analysis with data available (22 -25,28) showed consistent association in men (1.57, 1.30 -1.89) and women (1.83, 1.35 -2.48). The review by IARC did not report a quantitative summary of association; however, summary statistics in this study are within the range of reported RRs in the reviewed studies (1). This might suggest that an impact of smoking on pancreas cancer risk in the Japanese population is similar to that in other populations.
There were several potential limitations in the Japanese studies in this systematic review. One methodological issue was assessment of smoking exposures, which was investigated by a questionnaire in all cohort and case -control studies; therefore, it is difficult to completely exclude possible misclassification. Moreover, the definition and categorization of smoking exposure were heterogeneous across studies. These might bias the measure of association between cigarette smoking and pancreas cancer risk toward the null hypothesis. Recall bias might intensify the association; however, it would be unlikely because the significant association we observed was mainly from cohort studies. Lastly, the meta-analysis showed that ever smokers had significantly increased risk for pancreas cancer than never smokers. As the quantitative measurement of cigarette consumption was heterogeneous across studies, we could not evaluate the dose -response or frequency -response relationships within the meta-analysis. Therefore, a pooled analysis using common cigarette-smoking categories is essential to quantify a dose -response or frequency -response relationship in the Japanese population.
EVALUATION OF EVIDENCE ON CIGARETTE SMOKING AND PANCREAS CANCER RISK IN JAPANESE
From these results, we conclude that there is convincing evidence that cigarette smoking moderately increases the risk of pancreas cancer in the Japanese population.
